Related Experiment Videos
Nitric oxide and nitric oxide synthase in Huntington's disease
1Department of Psychiatry, Program in Neuroscience and Huntington's Disease Program, University of Connecticut Medical School, Farmington, Connecticut 03060-2103, USA. deckel@psychiatry.uchc.edu
Journal of Neuroscience Research
|April 5, 2001
Summary
Nitric oxide (NO) plays a dual role in Huntington's disease (HD) neuropathology. This review explores how nitric oxide synthase (NOS) activity influences HD progression, highlighting potential therapeutic targets.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Nitric oxide (NO) is a critical signaling molecule involved in numerous physiological processes.
- NO production, regulated by nitric oxide synthase (NOS), can be protective or detrimental in neuropathology.
- Huntington's disease (HD) is a progressive neurodegenerative disorder with complex underlying mechanisms.
Purpose of the Study:
- To review the properties of NO and NOS.
- To examine the pathophysiology of Huntington's disease (HD).
- To explore the interaction between NO/NOS and the HD-related protein, and their role in HD neuropathology.
Main Methods:
- Literature review of existing research on NO, NOS, and Huntington's disease.
- Analysis of data implicating NOS in HD neuropathology.
- Synthesis of current information on NO/NOS contribution to HD pathology.
Main Results:
- NO and NOS are implicated in the neuropathology of Huntington's disease.
- The role of NO/NOS in HD can be either protective or toxic, depending on disease stage and NOS isoforms.
- Interactions between NO/NOS and the HD-associated protein are discussed.
Conclusions:
- NO and NOS are significant factors in Huntington's disease pathogenesis.
- Understanding the dual role of NO/NOS offers potential avenues for therapeutic intervention in HD.
- Further research is needed to elucidate specific mechanisms and identify therapeutic targets.